INHSU 2025

14-17 October 2025

Century City Conference Centre
Cape Town, South Africa

The 13th International Conference
on Health and Hepatitis
in Substance Users

 

INHSU 2025 Co-Conveners and Committees

 

Our conference would not be possible without the tireless knowledge and expertise of our local co-conveners, international executive committee, program committee, and other committees. Thank you to everyone involved. 

Executive Committee

 

The INHSU 2025 Executive Committee provides strategic oversight and guidance for the conference, helping to shape the program, support decision-making, and ensure the event reflects the needs and priorities of the local and global community. 

Co-convener: Dr. Andrew Schiebe, Technical Advisor, TB HIV Care, Researcher, University of Pretoria.

Co-Convener: Angela McBride, Executive Director, South African Network of People Who Use Drugs

Emma Day, Executive Director, INHSU

Helgar Musyoki, Global Fund, Kenya

Professor Jason Grebely, The Kirby Institute, UNSW Sydney and President, INHSU, Australia

Kennedy Kipkoech, University of Bristol, UK

 Kgomotso Vilakazi Nhlapo, South African National Department of Health, South Africa

Professor Monique Marks, University of KwaZulu-Natal and University of Cape Town, South Africa

 

 Professor Natasha Martin, University of California San Diego, United States

 

Neliswa Gogela, University of Cape Town, South Africa

Program Committee

 

The INHSU 2025 Program Committee is responsible for developing the conference program and ensuring the content is relevant, high-quality, and reflective of the diverse experiences and expertise across the network.

  • Ansley Lyn, Division of Global HIV & TB, Centers for Disease Control and Prevention
  • Athalia Shabangu, National Department of Social Development
  • Brendan Harney, Research Officer, Burnet Institute
  • Chris Kassianides, African Gastroenterology, University of Cape Town
  • Ernst Wisse, Harm Reduction Advisor, Médecins du Monde
  • Harry Hausler, TB HIV Care
  • Jess Morales
  • Julie MacDonnell, JMD Consulting
  • Marie Jauffret-Roustide, Research Fellow, Inserm
  • Melisa Dickie, Director, Hepatitis C and Harm Reduction Knowledge Mobilization, CATIE
  • Mia Biondi, Nurse Practitioner, University of Toronto